Growth Metrics

TransMedics (TMDX) Free Cash Flow (2018 - 2026)

TransMedics has reported Free Cash Flow over the past 8 years, most recently at $76.5 million for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 42.8% year-over-year to $76.5 million; the TTM value through Dec 2025 reached $191.1 million, up 308.82%, while the annual FY2025 figure was $191.1 million, 308.82% up from the prior year.
  • Free Cash Flow for Q4 2025 was $76.5 million at TransMedics, up from $61.9 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $133.7 million in Q4 2024 and troughed at -$41.3 million in Q3 2024.
  • A 5-year average of $6.7 million and a median of -$7.8 million in 2021 define the central range for Free Cash Flow.
  • On a YoY basis, Free Cash Flow climbed as much as 1665.76% in 2024 and fell as far as 557.85% in 2024.
  • Year by year, Free Cash Flow stood at -$7.5 million in 2021, then crashed by 100.03% to -$15.0 million in 2022, then surged by 150.44% to $7.6 million in 2023, then skyrocketed by 1665.76% to $133.7 million in 2024, then crashed by 42.8% to $76.5 million in 2025.
  • Business Quant data shows Free Cash Flow for TMDX at $76.5 million in Q4 2025, $61.9 million in Q3 2025, and $82.5 million in Q2 2025.